ULCERATIVE COLITIS (UC)
Clinical trials for ULCERATIVE COLITIS (UC) explained in plain language.
Never miss a new study
Get alerted when new ULCERATIVE COLITIS (UC) trials appear
Sign up with your email to follow new studies for ULCERATIVE COLITIS (UC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug shows promise for maintaining ulcerative colitis remission
Disease control OngoingThis study tests whether risankizumab can help people with ulcerative colitis stay in remission (symptom-free) for up to a year. Participants had already responded to risankizumab in an earlier study. The trial compares risankizumab to a placebo to see if it prevents flare-ups an…
Matched conditions: ULCERATIVE COLITIS (UC)
Phase: PHASE3 • Sponsor: AbbVie • Aim: Disease control
Last updated Jun 16, 2026 12:49 UTC
-
New pill shows promise for Long-Term control of ulcerative colitis
Disease control OngoingThis study looks at the long-term safety and effectiveness of the drug upadacitinib for people with ulcerative colitis, a chronic bowel disease causing inflammation and ulcers. About 950 adults who did not improve enough or lost response to earlier treatment in related studies wi…
Matched conditions: ULCERATIVE COLITIS (UC)
Phase: PHASE3 • Sponsor: AbbVie • Aim: Disease control
Last updated Jun 15, 2026 19:08 UTC
-
IBD Patients' Well-Being under the microscope: new survey launches
Knowledge-focused ENROLLING_BY_INVITATIONThis study aims to understand how inflammatory bowel disease (IBD) impacts daily life and well-being. Researchers will survey 385 adults with Crohn's disease or ulcerative colitis about their symptoms, social support, and spiritual health. The goal is to identify factors that imp…
Matched conditions: ULCERATIVE COLITIS (UC)
Sponsor: Cairo University • Aim: Knowledge-focused
Last updated Jun 08, 2026 13:09 UTC